68.20.Z - Rental and management of own or leased real estate
41.10.Z - Construction work related to the construction of residential and non-residential buildings
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.10.Z - Real estate activities on own account and development of building projects
70.22.Z - Head office activities and management consultancy
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,9 | 0,9 | 1 | 0,9 |
Gross profit (loss) | 0,8 | 0,8 | 0,8 | -3,8 |
EBITDA | 1,1 | 1,2 | 1 | -10,8 |
Short time liabilities | 2,6 | 2,3 | 2 | -13,7 |
Other operating costs | 0 | 0 | 0,1 | 41 320,4 |
Equity capital | 3,1 | 3,6 | 4 | 11,3 |
Operating profit (EBIT) | 0,9 | 0,9 | 0,8 | -13,2 |
Assets | 7,8 | 7,6 | 7,4 | -3,3 |
Net profit (loss) | 0,8 | 0,7 | 0,7 | -5,4 |
Cash | 0 | 0,1 | 0,4 | 406,8 |
Net income from sale | 1,2 | 1,2 | 1,2 | -0,2 |
Liabilities and provisions for liabilities | 4,6 | 4 | 3,4 | -16,3 |
Working assets | 0,2 | 0,2 | 0,4 | 95,6 |
Other income costs | 0 | 0 | 0 | 41,2 |
Depreciation | 0,2 | 0,2 | 0,2 | 0 |
% | % | % | p.p. | |
Profitability of capital | 24,4 | 19,9 | 16,9 | -3 |
Equity capital to total assets | 40,5 | 47,1 | 54,2 | 7,1 |
Gross profit margin | 69,1 | 63,3 | 61 | -2,3 |
EBITDA Margin | 93,9 | 93,9 | 83,9 | -10 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 803 | 689 | 595 | -94 |
Current financial liquidity indicator | 0.06911133974790573 | 0.0980554148554802 | 0.22233624756336212 | 0,1 |
Net dept to EBITDA | 2.087360143661499 | 1.663992166519165 | 1.1961983442306519 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane